Health · 4 views
Prescriptions Down 25%, Overdoses Cut in Half: What Stopped a Gabapentinoid Surge?
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 4 Community interest
Brief read Under 1 min brief 30 words
Summary
(MedPage Today) -- High-profile media coverage of the harms associated with the gabapentinoid pregabalin (Lyrica) and tighter safeguards coincided with fewer prescriptions and overdoses in Australia, a retrospective study showed.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Key brain area reveals distinct zones whose boundaries blur with ageContinue reading
- Personalized mobile health coaching offers new approach to preventing gestational diabetes in high-risk pregnanciesContinue reading
- Once considered junk, cellular 'chimeras' emerge as key to better cancer careContinue reading
- MD Defends 'The Pitt'; Dr. Glaucomflecken Talks Surprise Billing; Holiday Health PSAContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow